Conference on Clinical Drug Trials is Coming Up—and You’re Invited

Clinical trials are key to determining the safety and efficacy of medicines. But to do so, trials must be robust and ethical—and their full results must be reported publicly. Unfortunately, many…
Bobbi Klettke
5 September 2016

Next Gen Advocates Excel at HAI/HP4L Summer School on Access to Medicines

[vc_row][vc_column][vc_column_text]by Ancel.la Santos Quintano, Policy Advisor, Health Action International A strong civil society is an essential component of an advanced democracy. To facilitate participation in policy-making processes, civil society groups need…
Bobbi Klettke
27 July 2016

Farewell to Access to Medicines Pioneer, Andrew Herxheimer

by TIM REED With a heavy heart, I write with news of the passing HAI founder, life member of the HAI European network, and our dear friend, Andrew Herxheimer, who passed away…
Bobbi Klettke
23 February 2016

Insulin Still Unattainable for Many Living with Diabetes Worldwide: ACCISS Study Review in The Lancet D&E

by MOLLY LEPESKA An ACCISS Study Review of the global insulin market, called ‘Constraints and Challenges in Access to Insulin: A Global Perspective, was published Friday in The Lancet Diabetes…
Bobbi Klettke
6 February 2016

HAI Launches Innovative Global Study to Improve Access to Insulin

by MARG EWEN, Global Pricing Co-ordinator and ACCISS Study Co-investigator The global need for insulin, a hormone that converts sugar, starches and other food into needed energy for everyday activities,…
Chris Verra Media
16 January 2015